Contributor Page
Morgan & Finnegan LLP
Email  |  Articles
Contact Details
Tel: +1 212 7584800
Fax: +1 212 7516849
345 Park Avenue
New York
NY 10154-0053
United States
By Tony Pezzano
Attorneys unfamiliar with the unique aspects of patent litigation may be surprised to learn that a judgment disposing of all liability issues in a patent infringement case is not always appealable to the Court of Appeals for the Federal Circuit.
By Tony Pezzano
As an incentive for generic pharmaceutical companies to rapidly bring generic drugs to market, Congress rewarded the first generic company to challenge the innovator company’s patent for a given drug with a 180-day exclusivity period in which no subsequent abbreviated new drug application ("ANDA") could be approved for that drug.